Yao Wu Selected Research

Radiofrequency Ablation

8/2019	Ultrasonic Cavitation Ameliorates Antitumor Efficacy of Residual Cancer After Incomplete Radiofrequency Ablation in Rabbit VX2 Liver Tumor Model.
1/2019	The TGF-β/Smad Pathway Inhibitor SB431542 Enhances The Antitumor Effect Of Radiofrequency Ablation On Bladder Cancer Cells.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Yao Wu Research Topics

Disease

70	Neoplasms (Cancer) 04/2024 - 06/2009
22	Sepsis (Septicemia) 03/2024 - 06/2007
16	Neoplasm Metastasis (Metastasis) 01/2024 - 01/2015
12	Inflammation (Inflammations) 01/2024 - 09/2015
10	Infections 01/2023 - 01/2016
9	Circulating Neoplastic Cells 04/2024 - 04/2018
9	Carcinogenesis 11/2023 - 11/2013
7	Colorectal Neoplasms (Colorectal Cancer) 05/2022 - 01/2014
6	Atherosclerosis 04/2024 - 09/2015
6	Ovarian Neoplasms (Ovarian Cancer) 07/2020 - 02/2015
5	Traumatic Brain Injuries (Traumatic Brain Injury) 05/2023 - 01/2020
5	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 08/2022 - 10/2017
5	Fibrosis (Cirrhosis) 04/2022 - 01/2018
5	Cardiovascular Diseases (Cardiovascular Disease) 01/2021 - 07/2018
5	Hepatocellular Carcinoma (Hepatoma) 01/2020 - 01/2012
4	Nasopharyngeal Carcinoma 01/2024 - 01/2015
4	Hypoxia (Hypoxemia) 11/2022 - 01/2014
4	Congenital Heart Defects (Congenital Heart Defect) 06/2022 - 09/2013
4	Hypertrophy 04/2022 - 12/2016
4	Pathologic Processes 11/2021 - 08/2009
4	Carcinoma (Carcinomatosis) 01/2020 - 06/2009
3	Cerebral Hemorrhage 03/2024 - 01/2020
3	Prostatic Neoplasms (Prostate Cancer) 02/2024 - 01/2019
3	Cognitive Dysfunction 12/2023 - 12/2020
3	Parkinson Disease (Parkinson's Disease) 12/2023 - 02/2023
3	Insulin Resistance 11/2023 - 09/2020
3	Leukemia 11/2023 - 01/2022
3	Ischemic Stroke 11/2023 - 01/2019
3	Hemangioma (Angioma) 04/2023 - 01/2020
3	Neuralgia (Stump Neuralgia) 01/2023 - 11/2020
3	Cardiotoxicity 01/2023 - 12/2016
3	Osteoporosis 10/2022 - 04/2020
3	Glioma (Gliomas) 09/2022 - 10/2017
3	Lung Neoplasms (Lung Cancer) 08/2022 - 01/2021
3	Cardiomegaly (Heart Hypertrophy) 04/2022 - 01/2018
3	Virus Diseases (Viral Diseases) 01/2022 - 01/2016
3	Breast Neoplasms (Breast Cancer) 01/2022 - 01/2012
3	Hypertension (High Blood Pressure) 12/2019 - 09/2018
3	Mucocutaneous Lymph Node Syndrome (Kawasaki Disease) 01/2019 - 11/2017
3	Heart Failure 10/2018 - 01/2017
3	Cholangiocarcinoma 09/2018 - 07/2015
3	Colonic Neoplasms (Colon Cancer) 10/2016 - 10/2013
3	Tetralogy of Fallot (Fallot Tetralogy) 05/2014 - 05/2012
2	Communicable Diseases (Infectious Diseases) 04/2024 - 09/2017
2	Bacterial Infections (Bacterial Infection) 01/2024 - 10/2022

Drug/Important Bio-Agent (IBA)

26	Proteins (Proteins, Gene)FDA Link 11/2023 - 07/2012
12	Biomarkers (Surrogate Marker)IBA 03/2024 - 09/2020
12	MicroRNAs (MicroRNA)IBA 11/2023 - 09/2013
10	DNA (Deoxyribonucleic Acid)IBA 03/2024 - 05/2012
9	Particulate MatterIBA 11/2023 - 10/2018
7	Reactive Oxygen Species (Oxygen Radicals)IBA 01/2023 - 08/2015
6	Glucose (Dextrose)FDA LinkGeneric 01/2024 - 08/2016
6	CytokinesIBA 01/2023 - 07/2012
6	Transcription Factors (Transcription Factor)IBA 01/2018 - 10/2013
5	antineoplaston A10 (A 10)IBA 04/2024 - 01/2019
5	LipopolysaccharidesIBA 03/2024 - 01/2019
5	Apolipoproteins E (ApoE)IBA 12/2021 - 09/2015
4	AntigensIBA 03/2024 - 01/2021
4	Cisplatin (Platino)FDA LinkGeneric 01/2024 - 07/2015
4	Therapeutic UsesIBA 01/2024 - 08/2021
4	Insulin (Novolin)FDA Link 03/2023 - 09/2020
4	Doxorubicin (Adriamycin)FDA LinkGeneric 01/2023 - 12/2009
4	RNA (Ribonucleic Acid)IBA 01/2023 - 01/2022
4	AntioxidantsIBA 01/2023 - 03/2016
4	LigandsIBA 10/2022 - 08/2009
4	ErbB Receptors (EGF Receptor)IBA 08/2022 - 10/2017
4	acacetinIBA 04/2022 - 01/2018
4	Messenger RNA (mRNA)IBA 01/2022 - 06/2007
4	LipidsIBA 01/2022 - 05/2018
4	ApolipoproteinsIBA 12/2021 - 09/2015
4	PhosphopeptidesIBA 11/2021 - 01/2020
4	HMGB1 Protein (HMG1)IBA 01/2021 - 07/2012
4	Fluorouracil (Carac)FDA LinkGeneric 05/2017 - 11/2013
3	MetalsIBA 03/2024 - 01/2014
3	XuebijingIBA 01/2024 - 06/2007
3	Lipoproteins (Lipoprotein)IBA 01/2024 - 04/2022
3	Epithelial Cell Adhesion MoleculeIBA 11/2023 - 04/2018
3	InterferonsIBA 10/2023 - 04/2022
3	Indicators and Reagents (Reagents)IBA 05/2023 - 03/2015
3	Xue-Fu-Zhu-Yu decoctionIBA 07/2022 - 01/2020
3	flavoneIBA 04/2022 - 01/2018
3	Angiotensin IIIBA 04/2022 - 01/2018
3	Protein CoronaIBA 01/2022 - 01/2014
3	GlycopeptidesIBA 01/2022 - 01/2021
3	CateninsIBA 08/2021 - 10/2018
3	CholesterolIBA 01/2021 - 01/2012
2	Glycoproteins (Glycoprotein)IBA 04/2024 - 01/2022
2	Lanthanoid Series Elements (Lanthanides)IBA 03/2024 - 11/2023
2	PlatinumIBA 01/2024 - 07/2017
2	Anti-Bacterial Agents (Antibiotics)IBA 01/2024 - 01/2022
2	Peptide Hydrolases (Proteases)FDA Link 01/2024 - 01/2023

Therapy/Procedure

22	Therapeutics 01/2024 - 11/2013
9	Ligation 01/2024 - 08/2007
8	Punctures 01/2024 - 08/2007
7	Drug Therapy (Chemotherapy) 01/2023 - 10/2013
6	Immunotherapy 01/2024 - 01/2022
5	Radiotherapy 01/2023 - 10/2013
4	Length of Stay 01/2023 - 09/2020
3	Chinese Traditional Medicine (Traditional Chinese Medicine) 06/2023 - 08/2007
2	Stents 04/2024 - 01/2023